AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04904796 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: H-HABIT
Description: H-HABIT : Hand-Arm Bimanual Intensive Therapy (HABIT) in children with hemiplegia is a new intervention developed at Columbia University. HABIT aims to improve the use and coordination of both arms in daily function. Unlike CIMT, HABIT focuses on improving the ability to perform bimanual activities. Participants will be monitored via webcam-based software (i.e. ZOOM) while they performed the activities in their own home.
Study NCT06127355 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 500 mg of ursodeoxycholic acid (UDCA)
Description: Administration of 500 mg of ursodeoxycholic acid (UDCA) /day
Study NCT06127355 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: 500 mg of Placebo
Description: Administration of 500 mg of placebo /day
Study NCT06430190 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peginterferon α-2b injection
Description: Participants receive CO2 laser treatment followed by local injection of 36mcg of Peginterferon α-2b directly into the base of each treated wart, repeated weekly for 12 weeks, and then followed for another 12 weeks.
Study NCT06430190 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peginterferon α-2b injection
Description: Participants undergo CO2 laser treatment and then receive a weekly subcutaneous injection of 180mcg of Peginterferon α-2b for 12 weeks, and then followed for another 12 weeks.
Study NCT06430190 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CO2 laser
Description: On the day (baseline), CO2 laser treatment was performed to remove all warts, and the treatment range was 0.2cm around the lesion and the depth was up to the dermis. Wound disinfection after laser. Participants are treated with CO2 laser therapy only and are observed for 12 weeks, followed by another 12-week observation period without any additional adjuvant therapy.
Study NCT06430190 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CO2 laser
Description: On the day (baseline), CO2 laser treatment was performed to remove all warts, and the treatment range was 0.2cm around the lesion and the depth was up to the dermis. Wound disinfection after laser. Participants are treated with CO2 laser therapy only and are observed for 12 weeks, followed by another 12-week observation period without any additional adjuvant therapy.
Study NCT05534997 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: intensive combined rehabilitation therapy
Description: graded exercise therapy and cognitive behavioral therapy
Study NCT04808024 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: SelfMyofascial Release
Description: Myofascial auto-release consisted of rolling the roller on a group of knee flexors for 3.5 minutes between the sciatic tumor and the knee joint in both directions, omitting the popliteal fossa. Before and after the intervention, sEMG of the biceps and gluteal muscles will be performed.
Study NCT05518136 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise-guidance on rehab APP
Description: Training motions included sitting balance, hand support, crawling and squatting training12-14 were scheduled for 1 to 3 months postoperatively, moreover, climbing over obstacles was for 3 to 6 months.
Study NCT05944094 — intervention group
Intervention type: DEVICE
Intervention: Clorhexidine
Description: Antiseptic treatment aimed at reducing potential bacterial overgrowth consisted of 10 days (1 box) of vaginal ovules of CLX (CumLaude CLX ® , CLX digluconate 0.2%) always starting between 10+0 and 16+0 weeks.
Study NCT05346588 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Anesthetic technique Propofol TIVA
Description: Propofol TIVA no inhaled agent
Study NCT05260125 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided Suprascapular Nerve Block
Description: For suprascapular nerve block, a solution consisting of 5 ml 2% lidocaine, 1 ml Betamethasone dipropionate + Betamethasone sodium phosphate (6.43 mg/ml + 2.63 mg/ml), 4 ml saline will be used.~Injections will be applied to patients in a sitting position and arm by the side. A linear probe with a frequency of 7-8 MHz on the SonoScape A8 ultrasound device will be used for suprascapular block under ultrasound guidance. the ultrasound probe was placed in the coronal plane over the suprascapular fossa. Suprascapular fossa was scanned from medial to lateral side to identify suprascapular nerve. After identification, solution of suprascapular nerve block will be injected into the area around the nerve under the scanning with in-plane technique with a 22 gauge 90 mm spinal needle.
Study NCT05346588 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Anesthetic technique inhaled agent
Description: must administer inhaled agent.
Study NCT05160779 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Analysis of genetic polymorphisms of vasoactive peptides in COVID-19
Description: Evaluate the frequency of the insertion/deletion (I/D) polymorphism in the ACE gene; to assess the frequency of polymorphism in the bradykinin B2 receptor gene; to assess the frequency of the polymorphism in the CK-M gene and compare the frequencies of these polymorphisms between patients with severe and mild conditions.
Study NCT06132659 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional magnetic resonance imaging (fMRI) with Veritable-NF
Description: Participants will have 4 visits (some can be done virtually). The baseline visit will include an interview and questionnaires. Eligible participants will have a practice session at visit 2, and may do a mock scanner if the visit is in person. Visit 3 will take place within 5 days of the practice session and participants will be asked to complete questionnaires and have an fMRI with the real neurofeedback. Visit 4 will take place one month after visit 3 and will include a follow-up interview with a trainer assessor as well as questionnaires. Additionally, 2 weeks after visit 3 participants will also complete some questionnaires online.
Study NCT06132659 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: fMRI with Sham-NF
Description: Participants will have 4 visits (some can be done virtually). The baseline visit will include an interview and questionnaires. Eligible participants will have a practice session at visit 2, and may do a mock scanner if the visit is in person. Visit 3 will take place within 5 days of the practice session and participants will be asked to complete questionnaires and have an fMRI with feedback that looks similar to real neurofeedback, but is computer generated. Visit 4 will take place 2 weeks after visit 3 and participants will complete more questionnaires.
Study NCT05662436 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Open Sky School program
Description: Teachers lead students in 2 hours of outdoor activities per week for 12 weeks, as detailed in the arm description
Study NCT05260125 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anatomical Landmark-guided Suprascapular Nerve Block
Description: For suprascapular nerve block, a solution consisting of 5 ml 2% lidocaine, 1 ml Betamethasone dipropionate + Betamethasone sodium phosphate (6.43 mg/ml + 2.63 mg/ml), 4 ml saline will be used.~Injections will be applied to patients in a sitting position and arm by the side. The suprascapular notch projection will be determined using the anatomical landmark technique defined by Dangoisse et al., and then suprascapular nerve block will be applied with a 22 gauge 90 mm spinal needle to the patients
Study NCT06454565 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Qigong - 12-Step Daoyin Health Preservation Exercises
Description: All participants received a six-month intervention consisting of two phases: the first month was a movement learning and consolidation phase of 45 minutes per session, once a day; the second five months were a formal practice phase of 45 minutes per session, once a day. In the first phase, participants learn four new movements per session and consolidate these exercises in the next session. After learning all the movements, the remaining time of the first phase was used to consolidate the exercises. In the second phase, participants perform a full Health Qigong - 12-Step Daoyin Health Preservation Exercises practice in each session.
Study NCT06454565 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Locked exercise
Description: All participants received a six-month intervention of 45 minutes once a day. All participants performed blocked aerobic exercise.
Study NCT06454565 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multiplayer open exercise
Description: All participants received a six-month intervention in the form of a balloon game competition. The intervention consisted of two phases: the first month consisted of a movement learning and consolidation phase of 45 minutes per session, once a day; the second five months consisted of a formal competition phase of 45 minutes per session, once a day. In the first phase, coaches taught participants the technical movements and rules. In the second phase, participants competed in groups during each session, with the coaches acting as referees.
Study NCT06454565 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Qigong - 12-Step Daoyin Health Preservation Exercises combined with locked exercise
Description: All participants received the intervention for six months, 45 minutes each time, once a day. All participants performed blocked exercise followed by Health Qigong - 12-Step Daoyin Health Preservation Exercises. The schedule was consistent with the Health Qigong - 12-Step Daoyin Health Preservation Exercises group and the Blocked Exercise group.
Study NCT06454565 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Qigong - 12-Step Daoyin Health Preservation Exercises combined with open exercise
Description: All participants received the intervention for six months, 45 minutes each time, once a day. All participants performed multiplayer Open Exercise followed by Health Qigong - 12-Step Daoyin Health Preservation Exercises exercises. The schedule was consistent with the Health Qigong - 12-Step Daoyin Health Preservation Exercises group and the Multiplayer Open Exercise group.
Study NCT06108440 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: action observation training
Description: Patients in Group A will receive action observation training with conventional treatment. All participants will undergo the training for 25 minutes per session, 5 days per week for 8 weeks.
Study NCT06108440 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: motor imagery training
Description: Patients in Group B will receive motor imagery with conventional treatment. All participants will receive interventions for twenty-five minutes per session, five times a week, for eight weeks.
Study NCT05553652 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: ASTARTE™ oral capsules
Description: 1 Capsule daily for 6 months
Study NCT05553652 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: ASTARTE™ oral capsules
Description: 1 Capsule daily for 6 months
Study NCT05553652 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Placebo oral capsules
Description: 1 Capsule daily for 6 months
Study NCT05553652 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral capsules
Description: 1 Capsule daily for 6 months
Study NCT04388865 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control
Description: Subjects will engage with their providers as is standard of care.
Study NCT04388865 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text-based Clinical Hovering
Description: Subjects will receive remote monitoring via text messaging of clinical symptoms and medication adherence reminders with feedback to social support.
Study NCT05242666 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: 3T MR Imaging of the cervical spinal cord
Description: Patients will undergo either Magnetic Resonance Imaging of the Spinal Cord
Study NCT05242666 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Positron Emission Tomography using [11C]PIB
Description: Patients will undergo combination MRI/PET using a \[11C\]PIB radiotracer
Study NCT05242666 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: 3T MR Imaging of the Brain
Description: 3T MR Imaging of the Brain
Study NCT05914233 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-invasive ultrasound retinal stimulation Device
Description: Record user feelings during the device is working
Study NCT05242666 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: 7T MR Imaging of the Spinal Cord
Description: 7T MR Imaging of the Spinal Cord
Study NCT04833153 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Person-First - Please (PFP)
Description: PFP takes 10 weeks and consist of four modules: Information, Person, Autonomy and Dignity. Information module takes 1 hour contact on first week. The other modules will follow every third weeks, starting from week 2. So that on week 2, 5 and 8 researcher meet nurses in 4 hours education session. Between the modules, nurses can take contact online to the researcher.
Study NCT04746404 — intervention group
Intervention type: BEHAVIORAL
Intervention: Emotional Skills Development Program
Description: Emotional Skills Development Program (positive psychology)
Study NCT05732727 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antihypertensive algorithm
Description: Antihypertensive algorithm based on diuretics agents
Study NCT05732727 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: standard of care management for antihypertensive therapy intensification
Study NCT05161624 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Accuracy evaluation
Description: The design of the diagnostic trial will include 160 cases of liver tumors with indications for microwave ablation after a multidisciplinary consultation with clinicians (Multiple Disciplinary Team, MDT), including primary liver cancer and metastatic liver tumors, and the tumor diameter is less than 3 cm. The test subjects consist of three groups: a. path planning model, b. junior ablation specialists, c. senior ablation specialists. The three groups will perform microwave ablation path planning on 160 selected cases of liver tumors. The attending professor of the clinical medical group of the department is responsible for scoring, evaluating whether the design of the plan is reasonable, and then comparing the scoring results by using statistical methods to evaluate the accuracy and effectiveness of the path planning model established in this study.
Study NCT05626465 — intervention group
Intervention type: OTHER
Intervention: Blood test
Description: Proteomic analyses on serum
Study NCT06304051 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intermittent Oro-esophageal Tube Feeding
Description: Before each feeding, inside and outside of the tube was cleaned with water. During feeding, the patient should maintain a semi-reclining or sitting position with mouth opened, and the tube was inserted slowly and smoothly into the upper part of the esophagus by medical staffs while the appropriate depth of intubation was checked with the calibration markings on the tube wall. The distance from the incisors to the head part of the tube should be between 22-25 cm. However, the specific depth should be evaluated based on patients' feedback and adjusted accordingly. After insertion, the tail part of the tube should be put into a container full of water and the absence of continuous bubbles indicated a successful intubation. Then, the feeding was to be conducted three times per day with 50 ml per minute and 400-600ml for each feeding.
Study NCT06304051 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nasogastric Tube Feeding
Description: Within 4 hours after admission, the placement of the feeding tube was conducted by professional medical staffs and after intubation, the tube was secured to the patient's cheek with medical tape. The feeding was conducted once every 3-4 hours, with 200-300ml each time. The total feeding volume was determined based on daily requirements. The feeding content was formulated by the nutritionists based on the patient\&#39;s condition and relevant guidelines to reach the energy demand as 20-25 kcal/kg/day and protein supplementation of 1.2-2.0 g/kg/day for both two groups. For patients with limited tube feeding compliance, the investigators made appropriate adjustments to ensure that they were not at risk of severe malnutrition as much as possible.
Study NCT05535959 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VX-121/TEZ/D-IVA
Description: FDC tablet for oral administration.
Study NCT06121934 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carica Papaya Leaf Extract
Description: Active drug: CPLE 500mg 2 capsule t.i.d for 5 dayseive CPLE or placebo once daily for 5 days.
Study NCT06121934 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo: visually matched placebo 2 capsule t.i.d for 5 days
Study NCT05582824 — intervention group
Intervention type: OTHER
Intervention: Blood and urine test
Description: Daily blood and urine samples
Study NCT06140875 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Radiofrequency electromagnetic field treatment
Description: Radiofrequency electromagnetic field treatment using a carrier frequency of 13.56 MHz
Study NCT05615857 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Use of Endocuff during colonoscopy
Description: We will be adding the Endocuff device to the proximal end of the colonoscope, adding an additional tool to facilitate the visualization of the difficult-to-see mucosal areas as well as the rectum. There will be no need for retroflexion to evaluate the colon
Study NCT05701059 — intervention group
Intervention type: PROCEDURE
Intervention: Cervical arthroplasty
Description: A joint replacement procedure administered by inserting an artificial disc between the vertebrae to replace a natural spinal disc after it has been removed.
Study NCT05701059 — intervention group
Intervention type: DEVICE
Intervention: Semi-Constrained Nuvasive Simplify
Description: This weight-bearing implant consisting of PEEK (polyetheretherketone) endplates and one semi-constrained, fully articulating, mobile zirconia toughened alumina (ZTA) ceramic core will be administered by cervical arthroplasty into the specified single-level cervical region.
Study NCT05006651 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: McGrath MAC
Description: Intubaion with McGrath MAC
Study NCT05006651 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Trachway
Description: Intubaion with Trachway
Study NCT05075434 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Treatment
Description: This protocol will be the one prescribed by the health centre. It consists of calf stretching exercises, plantar fascia, proprioceptive exercises, ultrasound, magnetic therapy and gait re-education and proprioceptive exercises for 40-45 minutes. Participants will receive 8 treatment sessions spread over 4 weeks (2 sessions per week).
Study NCT05075434 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Treatment
Description: This protocol will be the one prescribed by the health centre. It consists of calf stretching exercises, plantar fascia, proprioceptive exercises, ultrasound, magnetic therapy and gait re-education and proprioceptive exercises for 40-45 minutes. Participants will receive 8 treatment sessions spread over 4 weeks (2 sessions per week).
Study NCT05075434 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diacutaneous fibrolysis
Description: 15 minutes of the treatment technique. The FD intervention will be carried out with the same duration and protocol for all participants.~The intervention protocol will be: Start with the point of maximum tension between the two muscle bellies of the calf and hamstring (reverse hook). Then work on the peroneus longus lateralis and soleus. Then the external calf muscle belly and soleus and the internal calf muscle belly and soleus. Then work on the tendon of the flexor hallucis proprio of the big toe and the inner edge of the Achilles tendon and peroneus longus. Then treatment of the peroneus longus with the peroneus brevis. Scraping of the insertion of the Achilles tendon, hooking of the internal and external part of the plantar fascia. Finally, longitudinal friction of the plantar fascia.
Study NCT04995666 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonak Audeo hearing aid
Description: Rechargeable hearing aid
Study NCT05027711 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: ITV (Internal target volume)-based Stereotactic Body Radiotherapy (ITV-SBRT)
Description: ITV (Internal target volume)-based Stereotactic Body Radiotherapy (ITV-SBRT)
Study NCT05027711 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: MRgSBRT (Magnetic Resonance-guided Stereotactic Body Radiotherapy)
Description: MRgSBRT (Magnetic Resonance-guided Stereotactic Body Radiotherapy)
Study NCT06378164 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: For the combined step training group, the participants will receive training on both volitional and reactive stepping. The training will last for 1 hours per session, 2 session per week for 4 weeks.
Study NCT06378164 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Active Control
Description: An active control group will be used to minimise the placebo and history effect. The group will also receive a 4-week programme with the frequency and duration of the training and the instructor-to-participant ratio that match the combined step training group. During training, they will perform exercises not specific to reducing fall risk.
Study NCT06052111 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Group F (fentanyl group)
Description: Fentanyl (1 μg/kg) was given intravenously slowly over 60 seconds before induction of anesthesia as loading dose followed by continuous infusion at a rate of (1μg/kg/hr) after intubation and was stopped 10 minutes before the end of surgery.